Corgi Genomics & Precision Medicine ETF (GNMX)

Assets	$2.80M
Expense Ratio	0.35%
PE Ratio	n/a
Shares Out	75,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,027
Open	37.44
Previous Close	37.35
Day's Range	37.44 - 37.73
52-Week Low	23.88
52-Week High	38.70
Beta	n/a
Holdings	59
Inception Date	May 6, 2026

About GNMX

Fund Home Page

The Corgi Genomics & Precision Medicine ETF (GNMX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks capital appreciation through a portfolio of companies tiedto thegenomics and precision medicine value chain, from sequencing platforms and bioinformatics engines to gene editors, molecular diagnostics, targeted therapies, and clinical data platforms. GNMX was launched on May 6, 2026 and is issued by Corgi.

• Asset Class: Equity
• Stock Exchange: Cboe BZX
• Ticker Symbol: GNMX
• ETF Provider: Corgi

Top 10 Holdings

47.16% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	8.40%
Thermo Fisher Scientific Inc.	TMO	8.39%
Vertex Pharmaceuticals Incorporated	VRTX	5.70%
Illumina, Inc.	ILMN	4.70%
10x Genomics, Inc.	TXG	3.85%
Guardant Health, Inc.	GH	3.65%
Revolution Medicines, Inc.	RVMD	3.42%
Twist Bioscience Corporation	TWST	3.12%
Iovance Biotherapeutics, Inc.	IOVA	3.10%
Genmab A/S	GMAB	2.81%

Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 5, 2026

Data Sources Report a data error